Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
Lawrence D. Jacobs(University at Buffalo, State University of New York), Roy W. Beck(Jaeb Center for Health Research), Jack H. Simon(University of Colorado Health), R. Phillip Kinkel(Cleveland Clinic), Carol M. Brownscheidle(University at Buffalo, State University of New York), T. J. Murray(Queen Elizabeth II Health Sciences Centre), Nancy A. Simonian(Biogen (United States)), Peter Slasor(Biogen (United States)), Alfred Sandrock(Biogen (United States))
Cited by 1,509Open Access
Abstract
Treatment with interferon beta has been shown to help patients with established multiple sclerosis, but it is not known whether initiating treatment at the time of a first clinical demyelinating event is of value.
Related Papers
No related papers found
Powered by citation graph analysis